• Skip to main content
  • Skip to secondary menu
  • Skip to footer

Technologies.org

Technology Trends: Follow the Money

  • Sponsored Post
    • Make a Contribution
    • Technology Job Posting
  • Technology Events 2022-2023
  • Technology Domains
  • Technology Markets
  • Venture Capital
  • Contact
    • About

COVID-19 Could Be Identified in Minutes via Mobile Technology

March 3, 2020 By Technologies.org Leave a Comment

Fast testing during viral outbreaks, such as the current COVID-19, could assist to prevent its spread, saving lives and money.

What if you had a handheld, battery-powered, real-time polymerase chain reaction (real-time PCR) device to take to the farm, the factory, or any site, that could fast test and relay sample data via an iPhone app – all potentially within 40 minutes.

Ubiquitome, a New Zealand company, has developed that device – the Liberty 16. Initial testing of the Liberty16 using COVID-19 sequences validated by the US CDC and approved by the US FDA for COVID-19 testing has been positive.

Now Ubiquitome is showing Liberty 16 to the world.

Ubiquitome received a last-minute request to speak at the 27th International Molecular Medicine Tri-Conference in San Francisco March 1 – 4. The conference focuses on emerging therapeutic, diagnostic and technology approaches to advance precision medicine, digital health and Bio-IT.

Called Liberty 16 because it can run 16 tests at the same time, it is a miniature DNA photocopier. It can amplify specific target DNA sequences to show the presence of any DNA of interest, whether that be human, animal, or wider environmental pathogens.

It has been successfully trialled internationally, most recently at Germany’s Friedrich-Loeffler Institute. There it was used to detect traces of the viral RNA of PPRV, a highly contagious disease that affects sheep and goats.

The Liberty 16 performed the same as the large laboratory-scale, real-time PCR machines currently being used to test for COVID-19.

Fresh from a US$1 million capital raise mostly from New Zealand angel investors, chairman and CEO Dr Paul Pickering says Ubiquitome is now validating Liberty 16 for mobile use during the COVID-19 outbreak.

Prior to Ubiquitome, Dr Pickering held executive and general management roles with real time PCR market leader Life Technologies/Thermo Fisher.

Fellow Ubiquitome director Richard Creager is a former chief science officer of Beckman Coulter.

Early successes for Liberty 16, including the detection of septicaemia in blood and urine to blood pathogens that cause septicaemia, led to the German institute trials. At Tri-Con in San Francisco Dr Pickering will present data from the tests in Germany and the United Kingdom to some of the world’s largest pharmaceutical companies and leading academics.

Related

Filed Under: Tech Tagged With: COVID-19

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Recent Posts

  • AWS Announces General Availability of Amazon EC2 C7g Instances Powered by AWS-designed Graviton3 Processors
  • Infinitum Electric Raises $80M in Series D Funding Led by Riverstone Holdings to Scale Production of Sustainable Motors
  • Introducing IonQ Forte, Improving Quantum Performance with a Software-Configurable Dynamic Laser System
  • Cloudflare Unveils New SQL Database Offering
  • Cloudflare announces Workers for Platforms
  • Intel is rolling out new processors designed for data centers
  • EU moves to wean itself off Russian fossil fuels
  • A New Hydrogen-Powered Behemoth
  • BAE Systems to Bring Next-Generation Electric Drive System to Heavy-Duty Industrial Vehicle Market
  • MEMS Speakers Are Replacing Balanced Armature Speakers

Media Partners

  • VPNW
  • S3H
  • OPINT
  • Press Media Release
  • OSINT
  • Digital Market
  • Briefly

Media Partners

  • Technology Conferences
  • Event Sharing Network
  • Defense Conferences
  • Cybersecurity Events
  • Event Calendar
  • Calendarial
  • Opinion
  • Venture Capital

Copyright © 2015 Technologies.org

Technologies, Market Analysis & Market Research Reports

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT